title: Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.
abstract: Paraoxonase lactonase activity protects against homocysteinylation; therefore, it can be a potential contributing factor to prevent atherosclerosis. We aimed to determine paraoxonase and HTLase activities and to clarify the relationship between HTLase activity and some cardiovascular risk factors, such as homocysteine, cystatin C asymmetric dimethylarginine (ADMA), and adipokines both in hemo dialyzed and transplanted patients. Among 114 hemodialyzed, 80 transplanted and 64 healthy control subjects, we investigated body mass index (BMI) as well as fasting serum contents of urea, uric acid, creatinine, cystatin C, homocysteine, glucose, lipids, total protein and albumin. Serum paraoxonase (PON 1) and HTLase activities were measured spectrophotometrically. ADMA, ADPN adiponectin, leptin (LEP) levels was determined with a sandwich enzyme-linked immunosorbent assay method. Dyslipidemic patients showed hypercholesterolemia, and high low-density lipoprotein (LDL); parallel with improved renal function, they displayed decreased cystatin C and homocysteine levels (P < .001). There was a significant negative correlation between PON 1 activity and cystatin C and homocysteine concentrations (P < .05). Obese patients revealed significantly higher LDL (P < .05) and leptin concentrations (P < .01). There was a significant positive correlation between PON 1 activity and adiponectin levels (P = .0276). Both dialyzed and transplanted patients displayed significantly lower HTLase activities compared to the control group (P < .001), particularly lower HTLase and PON 1 activities in dialyzed subjects compared with the transplanted group (P < .05). HTLase activity showed significant negative correlations with ADMA levels among the whole study population (P < .001), whereas positive associations were noted between PON 1 and HTLase activities (P < .001). HTLase activity may be a new predictor of cardiovascular risk in renal failure although it is modulated by other risk factors.
authors: Institute of Surgery, University of Debrecen Medical and Health Science Center, Debrecen, Hungary. Electronic address: sulineni@gmail.com.
authors: L
authors: L
authors: Locsey
authors: I
authors: I
authors: Seres
authors: F
authors: F
authors: Sztanek
authors: M
authors: M
authors: Harangi
authors: J
authors: J
authors: Padra
authors: D
authors: D
authors: Kovacs
authors: R
authors: R
authors: Fedor
authors: L
authors: L
authors: Asztalos
authors: G
authors: G
authors: Paragh
mesh_terms: D054392:Adipokines / Q000097:blood*; D000328:Adult; D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D043303:Aryldialkylphosphatase / Q000097:blood*; D050197:Atherosclerosis / Q000097:blood / Q000175:diagnosis / Q000201:enzymology / Q000209:etiology*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D002265:Carboxylic Ester Hydrolases / Q000097:blood*; D016022:Case-Control Studies; D003124:Colorimetry; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000201:enzymology / Q000601:surgery / Q000628:therapy*; D012307:Risk Factors; D013053:Spectrophotometry; D016896:Treatment Outcome
chemical_list: D054392:Adipokines; D015415:Biomarkers; D008055:Lipids; C018524:N,N-dimethylarginine; D002097:C-Reactive Protein; D001120:Arginine; D002265:Carboxylic Ester Hydrolases; C502233:homocysteine-thiolactonase, human; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human